Arecor Therapeutics plc (AIM: AREC)
London
· Delayed Price · Currency is GBP · Price in GBX79.50
+3.00 (3.92%)
Nov 19, 2024, 9:00 AM GMT+1
Arecor Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -8.67 | -8.55 | -9.26 | -6.17 | -2.75 | -2.19 | Upgrade
|
| Depreciation & Amortization | 0.41 | 0.49 | 0.34 | 0.17 | 0.17 | 0.15 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.5 | 0.64 | 0.5 | 0.48 | 0.32 | 0.46 | Upgrade
|
| Other Operating Activities | 0.82 | 0.69 | -0.71 | 0.48 | -0.34 | 0.8 | Upgrade
|
| Change in Accounts Receivable | 1.9 | -1 | -0.05 | -1.26 | 0.38 | 0.45 | Upgrade
|
| Change in Inventory | 1.12 | 0.36 | 0.59 | - | - | - | Upgrade
|
| Change in Accounts Payable | -1.7 | 1.38 | -2.2 | 0.84 | 0.36 | -0.13 | Upgrade
|
| Change in Other Net Operating Assets | 0.03 | 0.16 | - | - | - | - | Upgrade
|
| Operating Cash Flow | -5.58 | -5.84 | -10.78 | -5.45 | -1.86 | -0.46 | Upgrade
|
| Capital Expenditures | -0.09 | -0.15 | -0.3 | -0.07 | -0.05 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | 0.28 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.05 | - | - | - | Upgrade
|
| Investment in Securities | 1.6 | 6.38 | -8.04 | - | - | - | Upgrade
|
| Other Investing Activities | 0.18 | 0.28 | 0.11 | 0 | 0 | 0.01 | Upgrade
|
| Investing Cash Flow | 1.69 | 6.52 | -7.99 | -0.07 | -0.05 | -0.02 | Upgrade
|
| Long-Term Debt Issued | - | 0.04 | - | 2.5 | 1.91 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.3 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.2 | -0.17 | -0.11 | -0.05 | - | Upgrade
|
| Total Debt Repaid | -0.15 | -0.2 | -0.46 | -0.11 | -0.05 | -0.12 | Upgrade
|
| Net Debt Issued (Repaid) | -0.11 | -0.17 | -0.46 | 2.39 | 1.86 | -0.12 | Upgrade
|
| Issuance of Common Stock | - | - | 6 | 20 | - | 0 | Upgrade
|
| Other Financing Activities | -0.01 | -0.02 | -0.38 | -1.46 | -0.08 | -0.01 | Upgrade
|
| Financing Cash Flow | -0.12 | -0.18 | 5.16 | 20.93 | 1.77 | -0.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.07 | -0.17 | 0.06 | 0.01 | -0.04 | -0.03 | Upgrade
|
| Net Cash Flow | -4.08 | 0.33 | -13.55 | 15.42 | -0.18 | -0.64 | Upgrade
|
| Free Cash Flow | -5.68 | -5.99 | -11.08 | -5.52 | -1.91 | -0.49 | Upgrade
|
| Free Cash Flow Margin | -115.88% | -131.03% | -461.05% | -476.60% | -112.43% | -25.97% | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -0.20 | -0.38 | -0.24 | -0.12 | -0.03 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | -1.29 | -0.73 | -0.76 | -0.3 | -1.27 | Upgrade
|
| Levered Free Cash Flow | -2.57 | -3 | -7.06 | -3.6 | -1.48 | - | Upgrade
|
| Unlevered Free Cash Flow | -2.56 | -2.99 | -7.05 | -3.59 | -1.43 | - | Upgrade
|
| Change in Net Working Capital | -2.3 | -1.76 | 1.09 | 0.44 | -0.28 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.